HIV R4P no date logo

HIVR4P 2018 Header

Meet the Chairs

HIVR4P 2016 is chaired by four of the world’s leading experts in HIV prevention research.



Thomas Hope
Northwestern University, Evanston, USA

Dr. Hope's Podcast

Dr. Hope holds a dual appointment as a professor in the Northwestern University Feinberg School of Medicine in the Departments of Cell and Molecular Biology and Obstetrics and Gynecology. He also holds an appointment as a professor in biomedical engineering in the McCormick School of Engineering and Applied Sciences. He is internationally known for his work to define the mechanisms of HIV transmission and his studies of the cell biology of the early aspects of HIV replication.


Dr. Hope received his Ph.D. from the University of California, Berkeley, in immunology. During his postdoctoral training at the University of California, San Francisco, he began to study HIV Rev protein. His study of RNA export elements led to the discovery of the Woodchuck Hepatitis Virus Posttranscriptional Regulatory Element (WPRE), which is commonly used to stimulate gene expression levels in expression vectors and gene therapy applications. In 2004, Dr. Hope was selected as an Elizabeth Glaser Scientist.

Dr. Hope’s laboratory studies various aspects of HIV science, taking a cell biology approach. The centerpiece of this approach is microscopic imaging, which provides important information relating to context and dynamics of biological functions. To study the cell biology of HIV, the Hope lab has developed techniques and tools that allow the fluorescent labeling of HIV particles or viral proteins and the identification of infected cells. This technology now enables researchers to follow virions and infected cells from the tissue culture dish to whole animal models. Studies to define the mechanisms of transmission have recently redirected a large aspect of the lab to HIV prevention science, including vaccine and microbicide research.

Dr. Hope is the editor-in-chief of AIDS Research and Human Retroviruses and section editor of PLoS Pathogens. He has experience co-organizing large international HIV conferences, including Cold Spring Harbor “Retroviruses” (2007) and Keystone “HIV Pathogenesis” (2010, Santa Fe, NM). Read less...



Nelly Mugo
Kenya Medical Research Institute, Nairobi, Kenya

Dr. Mugo is the head of the Reproductive Adolescent Child Health Research Program at the Kenya Medical Research Institute (KEMRI). She is an obstetrician and gynecologist with more than 25 years of work experience in public hospitals and 15 years of active clinical research work in Kenya. She has provided regional oversight for 14 clinical trial sites in 7 African countries for the HSV/HIV transmission study and was a site investigator for the Partners PrEP study.


Dr. Mugo received her medical training at the University of Nairobi and earned her MPH with a major in epidemiology from the University of Washington. She conducts research on HIV-AIDS and cervical cancer prevention and currently leads a clinical research team in Thika, Kenya.

Dr. Mugo regularly reviews manuscripts for several peer-review journals and presents on topical issues on HIV/AIDS and reproductive health in local, regional and international meetings. She is a registered medical practitioner in Kenya, works as an honorary lecturer at the University of Nairobi, Department of Obstetrics and Gynecology, and provides part-time clinical services at Kenyatta National Hospital. Read less...

 Lynn Morris  

Lynn Morris
National Institute for Communicable Diseases, Johannesburg, South Africa

Dr. Morris is a medical scientist and head of the HIV Virology section within the Center for HIV and STIs at the National Institute for Communicable Diseases (NICD) in Johannesburg, South Africa. She holds a joint appointment as research professor at the University of the Witwatersrand in Johannesburg and is a research associate at CAPRISA.


Dr. Morris obtained her DPhil from the University of Oxford, England, studying macrophage biology. Thereafter, she studied T cell immunology on a postdoctoral fellowship at the Walter and Eliza Hall Institute of Medical Research in Australia. On returning to South Africa in 1993, Dr. Morris turned her attention to HIV vaccines, building a research laboratory that has made significant contributions to understanding how the neutralizing antibody response to HIV develops. Her laboratory performs end-point antibody assays for human clinical trials of HIV vaccines and is part of a number of networks, including the Duke CHAVI-ID, Gates CAVD and the HVTN.

Dr. Morris has published widely and has mentored numerous post-graduate students and postdoctoral fellows. She has considerable conference organizing experience, including co-chairing the AIDS Vaccine Conference in 2008, was previously a member of the IAVI Scientific Advisory Committee and is currently on the Board of Directors for the Global HIV Vaccine Enterprise. Read less...

Jeanne Marrazzo

Jeanne Marrazzo
University of Alabama at Birmingham, Birmingham, USA

Dr. Marrazzo is Professor of Medicine and Director of the Division of Infectious Diseases at the University of Alabama at Birmingham. She is internationally recognized for her research and education efforts in the field of sexually transmitted infections, especially as they affect women’s health. She is a Fellow of the American College of Physicians and of the Infectious Disease Society of America. She is the President of the American Board of Internal Medicine (ABIM) Council, and also chairs the ABIM Infectious Disease Specialty Board.


She conducts research on the human microbiome, specifically as it relates to female reproductive tract infections and hormonal contraception. Her other research interests include the prevention of HIV infection using biomedical interventions, including microbicides. Recently, she led the VOICE Study, a large study evaluating HIV pre-exposure prophylaxis administered vaginally and orally to women at high risk for HIV infection in sub-Saharan Africa conducted by the NIH-funded Microbicide Trials Network.

Other areas of research interest include pathogenesis and management of bacterial vaginosis; STD in HIV-infected persons; and management of antibiotic resistance in gonorrhea. Read less...

Hotel conference details 022416